Loading…
Jubilant Pharmova (JUBLPHARMA)₹966.00+2.44%Pharmaceuticals
At the end of the Jun 2026 quarter, Jubilant Pharmova's shareholders were: promoters 47.70%, FIIs 15.88%, DIIs 12.37%, public 23.51%, others 0.54%. Promoter holding is unchanged on the quarter. FII holding is down 1.53 percentage points from 17.41% a year earlier. 6.60% of promoter shares were pledged. It had 82,678 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 50.70% | 50.70% | 50.70% | 50.70% | 50.70% | 50.70% | 50.70% | 47.70% | 47.70% | 47.70% | 47.70% | 47.70% |
| FIIs | 23.21% | 20.30% | 19.07% | 19.51% | 17.95% | 16.97% | 17.24% | 17.41% | 16.57% | 15.97% | 15.91% | 15.88% |
| DIIs | 1.63% | 2.88% | 3.75% | 4.04% | 5.63% | 6.96% | 7.02% | 9.49% | 10.50% | 11.20% | 11.60% | 12.37% |
| Public | 23.88% | 25.55% | 25.91% | 25.18% | 25.17% | 24.82% | 24.49% | 24.85% | 24.61% | 24.57% | 24.24% | 23.51% |
| Others | 0.58% | 0.57% | 0.57% | 0.57% | 0.55% | 0.55% | 0.55% | 0.55% | 0.62% | 0.56% | 0.55% | 0.54% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 6.60% |
| Number of shareholders | 89,349 | 86,562 | 92,236 | 81,967 | 89,429 | 1,02,411 | 96,497 | 99,643 | 93,308 | 90,106 | 86,321 | 82,678 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Spb Trustee Company Pvt Ltd | Promoter | 20.13% | 0.00 |
| Hsb Trustee Company Pvt Ltd | Promoter | 19.03% | 0.00 |
| Rekha Jhunjhunwala - 2 | Public | 3.26% | +0.13 |
| Miller Holdings Pte Ltd | Promoter | 3.25% | 0.00 |
| Bandhan Small Cap Fund | DII | 3.23% | +0.85 |
| Mav Management Advisors Llp | Promoter | 3.14% | 0.00 |
| Government Pension Fund Global | FII | 3.13% | −0.07 |
| Rekha Jhunjhunwala - 3 | Public | 3.13% | New |
| East Bridge Capital Master Fund I Ltd | FII | 2.54% | 0.00 |
| Kotak Mahindra Trustee Co Ltd A/C Kotak Multicap Fund | DII | 2.42% | −0.02 |
| Theleme India Master Fund Limited | FII | 1.90% | +0.20 |
| Quant Mutual Fund - Quant Small Cap Fund | DII | 1.86% | 0.00 |
| Investor Education And Protection Fund Authority Ministry Of Corporate Affairs | Public | 1.24% | −0.02 |
| Abakkus Emerging Opportunities Fund-1 | DII | 1.14% | 0.00 |
| Sbi Life Insurance Co. Ltd | DII | 1.12% | 0.00 |
| Nikita Resources Private Limited | Promoter | 0.97% | 0.00 |
| Priyavrat Bhartia | Promoter | 0.88% | 0.00 |
| Hari Shanker Bhartia | Promoter | 0.23% | 0.00 |
| Shamit Bhartia | Promoter | 0.08% | 0.00 |
| Kavita Bhartia | Promoter | 0.01% | 0.00 |
| Rekha Jhunjhunwala | Public | Exited | — |
| Jubilant Enpro Private Limited | Promoter | 0.00% | 0.00 |
Promoters held 47.70% of Jubilant Pharmova at the end of the Jun 2026 quarter, the same as a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 15.88% (down 0.03 percentage points from 15.91% a quarter earlier) and domestic institutions (DIIs) held 12.37% (up 0.77 percentage points from 11.60% a quarter earlier).
Yes. 6.60% of promoter shares were pledged at the end of the Jun 2026 quarter.
Jubilant Pharmova had 82,678 shareholders at the end of the Jun 2026 quarter, against 99,643 a year earlier.
Rekha Jhunjhunwala - 2 (Public) held 3.26% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.